Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Revenue

Lincoln Pharmaceuticals had revenue of 1.77B INR in the quarter ending June 30, 2026, with 15.07% growth. This brings the company's revenue in the last twelve months to 6.94B, up 10.20% year-over-year. In the fiscal year ending March 31, 2026, Lincoln Pharmaceuticals had annual revenue of 6.71B with 7.67% growth.

• Revenue (ttm): 6.94B
• Revenue Growth: +10.20%
• P/S Ratio: 1.74
• Revenue / Employee: 5.13M
• Employees: 1,352
• Market Cap: 12.08B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.71B	478.00M	7.67%
Mar 31, 2025	6.23B	426.81M	7.35%
Mar 31, 2024	5.81B	702.41M	13.76%
Mar 31, 2023	5.10B	381.86M	8.09%
Mar 31, 2022	4.72B	479.38M	11.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 20, 2026

Data Sources Report a data error